About StragenStragen (STRAtegic GENerics) is a Swiss-founded international pharmaceutical group specialising in hard-to-make, complex generics and consumer health products for patients with serious, often life-threatening conditions. Founded in 1990 near Geneva, Stragen develops niche formulations across cardiology, anti-infectives and women's health, with more than 40 products commercialised in over 60 countries and a direct footprint in key markets, including Germany, France, the Nordics, the United States and Canada. The RoleReporting to the Chief Commercial & Business Development Officer, the Head of Commercial will own the German P&L end to end — building and evolving commercial channels, expanding the customer base, and winning hospital and insurance-group tenders to deliver Stragen's five-year strategic plan. The role leads a lean, commercially focused team across sales, marketing and supporting functions, while safeguarding compliance and quality.Key ResponsibilitiesOwn and grow the Germany P&L, delivering revenue, margin, cash and forecast-accuracy targetsLead commercial execution across hospital, private-group retail, insurance-group and tender channelsOwn tender strategy and delivery (Rabattverträge/GKV): pipeline, bid/no-bid, pricing, fulfilment and governanceEngage payers, purchasing bodies, wholesalers and pharmacy networks; optimise trade termsDevelop digital marketing and direct-to-patient strategiesBuild and manage Group-developed partnerships and co-promotion activitySupport corporate-driven BD/M&A projects with country business cases and post-deal integrationEnsure full compliance with AMG, HWG, FSA Code, GDP/GxP, Pharmacovigilance and GDPR, maintaining inspection readinessRecruit, coach and develop the teamRequirements10–15+ years in pharma/CHC, with proven sales or business-unit leadership in Germany§ 75 AMG Sachkenntnis (Pharmaberater / Geprüfte:r Pharmareferent:in), or an equivalent qualifying scientific degree, permitting direct professional engagement with pharmacies and prescribersStrong track record in sales growth and tender wins, with deep knowledge of the GKV/tender and payer ecosystemPartnership management and co-promotion experience; familiarity with Gx and specialty dossier suppliersCommercial finance acumen — pricing, contribution margin and working capitalFluent German and English, with excellent negotiation and stakeholder-management skillsBenefitsCompetitive base salary plus bonus, with German-market benefitsRemote/hybrid workingTravel approximately 30–40% within Germany, with occasional EU/global travel
About Stragen
Stragen (STRAtegic GENerics) is a Swiss-founded international pharmaceutical group specialising in hard-to-make, complex generics and consumer health products for patients with serious, often life-threatening conditions. Founded in 1990 near Geneva, Stragen develops niche formulations across cardiology, anti-infectives and women's health, with more than 40 products commercialised in over 60 countries and a direct footprint in key markets, including Germany, France, the Nordics, the United States and Canada.
The Role
Reporting to the Chief Commercial & Business Development Officer, the Head of Commercial will own the German P&L end to end — building and evolving commercial channels, expanding the customer base, and winning hospital and insurance-group tenders to deliver Stragen's five-year strategic plan. The role leads a lean, commercially focused team across sales, marketing and supporting functions, while safeguarding compliance and quality.
Key Responsibilities
- Own and grow the Germany P&L, delivering revenue, margin, cash and forecast-accuracy targets
- Lead commercial execution across hospital, private-group retail, insurance-group and tender channels
- Own tender strategy and delivery (Rabattverträge/GKV): pipeline, bid/no-bid, pricing, fulfilment and governance
- Engage payers, purchasing bodies, wholesalers and pharmacy networks; optimise trade terms
- Develop digital marketing and direct-to-patient strategies
- Build and manage Group-developed partnerships and co-promotion activity
- Support corporate-driven BD/M&A projects with country business cases and post-deal integration
- Ensure full compliance with AMG, HWG, FSA Code, GDP/GxP, Pharmacovigilance and GDPR, maintaining inspection readiness
- Recruit, coach and develop the team
Requirements
- 10–15+ years in pharma/CHC, with proven sales or business-unit leadership in Germany
- § 75 AMG Sachkenntnis (Pharmaberater / Geprüfte:r Pharmareferent:in), or an equivalent qualifying scientific degree, permitting direct professional engagement with pharmacies and prescribers
- Strong track record in sales growth and tender wins, with deep knowledge of the GKV/tender and payer ecosystem
- Partnership management and co-promotion experience; familiarity with Gx and specialty dossier suppliers
- Commercial finance acumen — pricing, contribution margin and working capital
- Fluent German and English, with excellent negotiation and stakeholder-management skills
Benefits
- Competitive base salary plus bonus, with German-market benefits
- Remote/hybrid working
- Travel approximately 30–40% within Germany, with occasional EU/global travel
With offices in the US, Europe and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to North American and European healthcare businesses.Prioritized areas of focus include Healthcare IT, MedTech, Pharma Services, Life Science Tools & Biologic Services, Biopharma Products, In Vitro Diagnostics, Consumer Health. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.Over the last twenty years, ARCHIMED's leadership team has directly managed and invested in over eighty small to large-size healthcare companies globally, representing over €50 billion of combined value. ARCHIMED manages €8 billion across its various funds. Since inception, ARCHIMED has been a committed Impact Investor, both directly and through its EURÊKA Foundation.The Team
An international team (British, French, German, Italian, Polish...) with complementary education and experience in the investment, medical, scientific, strategic and operational sectors
Composed of alumni from: INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, Ponts et Chaussées, ESSEC, Imperial College, Dartmouth, etc
Professional backgrounds: Private Equity (3i, Siparex, USS Ltd, Barings, capiton), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC), Industry (Biotronik, Cerba, Pharmacy, Veterinary)
With offices in the US, Europe and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to North American and European healthcare businesses.
Prioritized areas of focus include Healthcare IT, MedTech, Pharma Services, Life Science Tools & Biologic Services, Biopharma Products, In Vitro Diagnostics, Consumer Health. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.
Over the last twenty years, ARCHIMED's leadership team has directly managed and invested in over eighty small to large-size healthcare companies globally, representing over €50 billion of combined value. ARCHIMED manages €8 billion across its various funds. Since inception, ARCHIMED has been a committed Impact Investor, both directly and through its EURÊKA Foundation.
The Team
- An international team (British, French, German, Italian, Polish...) with complementary education and experience in the investment, medical, scientific, strategic and operational sectors
- Composed of alumni from: INSEAD, Berkeley, Georgetown, Bocconi, HEC Paris, Ponts et Chaussées, ESSEC, Imperial College, Dartmouth, etc
- Professional backgrounds: Private Equity (3i, Siparex, USS Ltd, Barings, capiton), Consulting (A.T. Kearney, Bain, McKinsey), M&A (Lazard, EY, KPMG, PwC), Industry (Biotronik, Cerba, Pharmacy, Veterinary)
